Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (Pfs) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (Fl): Biomarker Analyses of the Phase 3 Lym3001 Study

AuthID
P-002-JJW
25
Author(s)
Li, WM
·
Henitz, ED
·
Karkera, JD
·
Favis, R
·
Gaffney, D
·
Shapiro, A
·
Theocharous, P
·
Elsayed, YA
·
van de Velde, H
·
[+5]·
Teixeira, AC
·
Walewski, J
·
de Vos, S
·
Crump, M
·
Shpilberg, O
·
Zinzani, PL
·
Cakana, AZ
·
Esseltine, DL
·
Mulligan, G
·
Ricci, DS
Document Type
Abstract
Year published
2011
Published
in BLOOD, ISSN: 0006-4971
Volume: 118, Issue: 21, Pages: 122-122 (1)
Conference
53Rd Annual Meeting and Exposition of the American-Society-Of-Hematology (Ash)/Symposium on the Basic Science of Hemostasis and Thrombosis, Date: DEC 10-13, 2011, Location: San Diego, CA, Sponsors: Amer Soc Hematol (ASH)
Indexing
Publication Identifiers
Wos: WOS:000299597100266
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Coiffier, B;   2 Li, WM;   3 Henitz, ED;
4 Karkera, JD;   5 Favis, R;   6 Gaffney, D;
7 Shapiro, A;   8 Theocharous, P;   9 Elsayed, YA;
10 van de Velde, H;   11 Osmanov, EA;   12 Hong, XN;
13 Scheliga, A;   14 Offner, FC;   15 Rule, S;
16 Teixeira, AC;   17 Walewski, J;   18 de Vos, S;
19 Crump, M;   20 Shpilberg, O;   21 Zinzani, PL;
22 Cakana, AZ;   23 Esseltine, DL;   24 Mulligan, G;
25 Ricci, DS;